Japan’s FY26 price revision expands G1 repricing and drives price reduction
Japan’s latest National Health Insurance (NHI) drug price revision for FY26 has now come into effect, with an average 4.02% reduction in drug pr…
#Japan #JP #JapanNews #drugpricerevision #news #priceadjustments #pricechange #pricechanges #pricecuts #PriceMaintenance #pricereduction #pricereductions #pricerevision
https://www.alojapan.com/1484028/japans-fy26-price-revision-expands-g1-repricing-and-drives-price-reduction/